Literature DB >> 33468079

Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.

Shao-Hao Chen1, Long-Yao Xu1, Yu-Peng Wu1, Zhi-Bin Ke1, Peng Huang1, Fei Lin1, Xiao-Dong Li1, Xue-Yi Xue1, Yong Wei1, Qing-Shui Zheng2, Ning Xu3.   

Abstract

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is one of the most frequent malignancies; however, the present prognostic factors was deficient. This study aims to explore whether there is a relationship between tumor volume (TV) and oncological outcomes for localized ccRCC.
METHODS: Seven hundred forty-nine localized ccRCC patients underwent surgery in our hospital. TV was outlined and calculated using a three-dimensional conformal radiotherapy planning system. We used receiver operating characteristic (ROC) curves to identified optimal cut-off value. Univariable and multivariable Cox regression models were performed to explore the association between TV and oncological outcomes. Kaplan-Meier method and log-rank test were used to estimate survival probabilities and determine the significance, respectively. Time-dependent ROC curve was utilized to assess the prognostic effect.
RESULTS: Log rank test showed that higher Fuhrman grade, advanced pT classification and higher TV were associated with shortened OS, cancer-specific survival (CSS), freedom from metastasis (FFM) and freedom from local recurrence (FFLR). multivariable analysis showed higher Fuhrman grade and higher TV were predictors of adverse OS and CSS. The AUC of TV for FFLR was 0.822. The AUC of TV (0.864) for FFM was higher than that of pT classification (0.818) and Fuhrman grade (0.803). For OS and CSS, the AUC of TV was higher than that of Fuhrman grade (0.832 vs. 0.799; 0.829 vs 0.790).
CONCLUSIONS: High TV was an independent predictor of poor CSS, OS, FFLR and FFM of localized ccRCC. Compared with pT classification and Fuhrman grade, TV could be a new and better prognostic factor of oncological outcome of localized ccRCC, which might contribute to tailored follow-up or management strategies.

Entities:  

Keywords:  Localized clear cell renal cell carcinoma; Oncological outcome; Prognostic factor; Survival; Tumor volume

Year:  2021        PMID: 33468079      PMCID: PMC7816334          DOI: 10.1186/s12885-021-07795-8

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  35 in total

1.  Significance of TNM staging, Demographic and Histologic Features in Predicting the Prognosis of Renal Cell Carcinoma.

Authors:  U Kucuk; E E Pala; O Sezer; E Cakir; U Bayol; R T Divrik
Journal:  Acta Chir Belg       Date:  2015 May-Jun       Impact factor: 1.090

2.  Effect of parenchymal volume preservation on kidney function after partial nephrectomy.

Authors:  Matthew N Simmons; Amr F Fergany; Steven C Campbell
Journal:  J Urol       Date:  2011-06-15       Impact factor: 7.450

3.  NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

Authors:  Al B Benson; Michael I D'Angelica; Daniel E Abbott; Thomas A Abrams; Steven R Alberts; Daniel Anaya Saenz; Chandrakanth Are; Daniel B Brown; Daniel T Chang; Anne M Covey; William Hawkins; Renuka Iyer; Rojymon Jacob; Andrea Karachristos; R Kate Kelley; Robin Kim; Manisha Palta; James O Park; Vaibhav Sahai; Tracey Schefter; Carl Schmidt; Jason K Sicklick; Gagandeep Singh; Davendra Sohal; Stacey Stein; G Gary Tian; Jean-Nicolas Vauthey; Alan P Venook; Andrew X Zhu; Karin G Hoffmann; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2017-05       Impact factor: 11.908

4.  [Pathological prognostic indicators in renal cell carcinoma].

Authors:  J Rey Rey; D León Ramírez; S López García; P Fernández Vázquez; J Benavente Delgado; A Ojea Calvo
Journal:  Actas Urol Esp       Date:  2010-01       Impact factor: 0.994

5.  Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates.

Authors:  Paul L Crispen; Rodney H Breau; Cristine Allmer; Christine M Lohse; John C Cheville; Bradley C Leibovich; Michael L Blute
Journal:  Eur Urol       Date:  2010-09-15       Impact factor: 20.096

Review 6.  Treatment options and outcomes for caval thrombectomy and resection for renal cell carcinoma.

Authors:  Georges M Haidar; Taylor D Hicks; Hosam F El-Sayed; Mark G Davies
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2017-05

7.  Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.

Authors:  Mostafa Nazari; Isaac Shiri; Ghasem Hajianfar; Niki Oveisi; Hamid Abdollahi; Mohammad Reza Deevband; Mehrdad Oveisi; Habib Zaidi
Journal:  Radiol Med       Date:  2020-03-19       Impact factor: 3.469

8.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

Review 9.  Prognostic factors and prognostic models for renal cell carcinoma: a literature review.

Authors:  Tobias Klatte; Sabrina H Rossi; Grant D Stewart
Journal:  World J Urol       Date:  2018-04-30       Impact factor: 4.226

10.  Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.

Authors:  Bin Yang; Haizhui Xia; Chuxiao Xu; Min Lu; Shudong Zhang; Guoliang Wang; Lulin Ma
Journal:  BMC Urol       Date:  2020-02-18       Impact factor: 2.264

View more
  3 in total

1.  The Significant Role of Tumor Volume on the Surgical Approach Choice, Surgical Complexity, and Postoperative Complications in Renal Cell Carcinoma With Venous Tumor Thrombus From a Large Chinese Center Experience.

Authors:  Qais Baheen; Zhuo Liu; Yichang Hao; Rejean R R Sawh; Yuxuan Li; Xun Zhao; Peng Hong; Zonglong Wu; Lulin Ma
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

2.  DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis.

Authors:  Man-Gang Lee; Yung-Kuo Lee; Shih-Chung Huang; Chen-Lin Chang; Chou-Yuan Ko; Wen-Chin Lee; Tung-Yuan Chen; Shiow-Jyu Tzou; Cheng-Yi Huang; Ming-Hong Tai; Yu-Wei Lin; Mei-Lang Kung; Ming-Chao Tsai; Yung-Lung Chen; Yi-Chen Chang; Zhi-Hong Wen; Chao-Cheng Huang; Tian-Huei Chu
Journal:  Genes (Basel)       Date:  2022-04-01       Impact factor: 4.141

Review 3.  Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy.

Authors:  Leah Davis; Matthias Recktenwald; Evan Hutt; Schuyler Fuller; Madison Briggs; Arnav Goel; Nichole Daringer
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.